BCMA Re-Emergence As a Prognostic Indicator of Clinical Relapse after Chimeric Antigen Receptor T-Cell Therapy (CART) in Multiple Myeloma

被引：0
|
作者：
Rashid, Aliya [1 ,2 ,3 ]
Wesson, William [2 ,4 ,5 ]
Lutfi, Forat [1 ,5 ]
Mushtaq, Muhammad Umair [5 ]
McGuirk, Joseph P. [5 ,6 ]
Abdallah, Al-Ola
Cui, Wei [7 ]
Ahmed, Nausheen [5 ]
机构：
[1] US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USA
[2] Univ Kansas, Div Hematol Malignancies & Cellular Therapeut, Ctr Canc, Kansas City, MO USA
[3] Univ Kansas, Med Ctr, Internal Med, Kansas City, KS USA
[4] Univ Kansas, Sch Med, Kansas City, KS USA
[5] Univ Kansas, Div Hematol Malignancies & Cellular Therapeut, Med Ctr, Kansas City, KS USA
[6] Univ Kansas, Med Ctr, Westwood, KS USA
[7] Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-182126
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Chimeric antigen receptor T-cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice
    Parikh, Rujul H.
    Lonial, Sagar
    CA-A CANCER JOURNAL FOR CLINICIANS, 2023, 73 (03) : 275 - 285
  • [42] Factors associated with infection events after chimeric antigen receptor T-cell therapy for relapsed or refractory multiple myeloma
    Zhou, Dian
    Wang, Ying
    Cheng, Hai
    Zhu, Lili
    Chen, Wei
    Li, Hujun
    Zhang, Xiaotian
    Xia, Jieyun
    Qi, Yuekun
    Ma, Sha
    Zhu, Feng
    Yan, Zhiling
    Qi, Kunming
    Sang, Wei
    Sun, Haiying
    Li, Depeng
    Cao, Jiang
    Li, Zhenyu
    Xu, Kailin
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2023, 29 (02) : 179 - 185
  • [43] Prognostic impact of corticosteroid and tocilizumab use on the efficacy of chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma
    Costa, Bruno
    Flynn, Jessica
    Nath, Karthik
    Nishimura, Noriko
    Devlin, Sean
    Farzana, Tasmin
    Chung, David
    Landau, Heather
    Lahoud, Oscar
    Scordo, Michael
    Shah, Gunjan
    Hassoun, Hani
    Maclachlan, Kylee
    Hultcrantz, Malin
    Korde, Neha
    Lesokhin, Alexander
    Shah, Urvi
    Tan, Carlyn Rose
    Giralt, Sergio
    Usmani, Saad
    Mailankody, Sham
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S36 - S36
  • [44] Associations of T-cell fitness prior to B-cell maturation antigen (BCMA)-targeted chimeric antigen receptor T-cell (CART) and bispecific T-cell engager (BiTE) therapies and efficacy/toxicity in relapsed/refractory multiple myeloma (RRMM)
    Theprungsirikul, Poy
    Yu, Mansen
    Rall, Kerri
    Matthews, Martin
    Neparidze, Natalia
    Parker, Terri L.
    Browning, Sabrina
    Anderson, Tara
    Stevens, Erica
    Foss, Francine M.
    Gowda, Lohith
    Pillai, Manoj
    Isufi, Iris
    Seropian, Stuart
    Mirza, Sayeef
    Bar, Noffar
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [45] Chimeric Antigen Receptor T-Cell Therapeutics for Multiple Myeloma Moving Into the Spotlight
    Wang, Bo
    Rajeeve, Sridevi
    Madduri, Deepu
    CANCER JOURNAL, 2021, 27 (03): : 205 - 212
  • [46] T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy
    Storgard, Ryan
    Rejeski, Kai
    Perales, Miguel-Angel
    Goldman, Adam
    Shouval, Roni
    JAMA ONCOLOGY, 2024, 10 (06) : 826 - 828
  • [47] Cost-Effectiveness of Anti-BCMA Chimeric Antigen Receptor T Cell Therapy in Relapsed/Refractory Multiple Myeloma
    Yamamoto, Chihiro
    Minakata, Daisuke
    Yokoyama, Daizo
    Furuki, Shuka
    Noguchi, Atsuto
    Koyama, Shunsuke
    Oyama, Takashi
    Murahashi, Rui
    Nakashima, Hirotomo
    Ikeda, Takashi
    Kawaguchi, Shin-ichiro
    Hyodo, Kazuki
    Toda, Yumiko
    Ito, Shoko
    Nagayama, Takashi
    Umino, Kento
    Morita, Kaoru
    Ashizawa, Masahiro
    Ueda, Masuzu
    Hatano, Kaoru
    Sato, Kazuya
    Ohmine, Ken
    Fujiwara, Shin-ichiro
    Kanda, Yoshinobu
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (01): : 118.e1 - 118.e15
  • [48] Chimeric antigen receptor T-cell therapy
    Burge, Cale
    Vanguru, Vinay
    Ho, Phoebe Joy
    AUSTRALIAN PRESCRIBER, 2023, 46 (02) : 36 - 39
  • [49] The Clinical Significance of Cytomegalovirus Viremia after Chimeric Antigen Receptor T-Cell Therapy
    Hammond, Sarah P.
    Little, Jessica S.
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (05) : 1318 - 1319
  • [50] Chimeric Antigen Receptor T-Cell Therapy
    Ogba, Ndiya
    Arwood, Nicole M.
    Bartlett, Nancy L.
    Bloom, Mara
    Brown, Patrick
    Brown, Christine
    Budde, Elizabeth Lihua
    Carlson, Robert
    Farnia, Stephanie
    Fry, Terry J.
    Garber, Morgan
    Gardner, Rebecca A.
    Gurschick, Lauren
    Kropf, Patricia
    Reitan, Jeff J.
    Sauter, Craig
    Shah, Bijal
    Shpall, Elizabeth J.
    Rosen, Steven T.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (09): : 1093 - 1106
12345